BINOSTO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Binosto, and when can generic versions of Binosto launch?
Binosto is a drug marketed by Ascend Theraps Us and is included in one NDA. There are three patents protecting this drug.
This drug has thirty-one patent family members in seventeen countries.
The generic ingredient in BINOSTO is alendronate sodium. There are twenty-five drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the alendronate sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Binosto
A generic version of BINOSTO was approved as alendronate sodium by APOTEX on August 4th, 2008.
Summary for BINOSTO
International Patents: | 31 |
US Patents: | 3 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 47 |
Clinical Trials: | 2 |
Patent Applications: | 111 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for BINOSTO |
What excipients (inactive ingredients) are in BINOSTO? | BINOSTO excipients list |
DailyMed Link: | BINOSTO at DailyMed |


Recent Clinical Trials for BINOSTO
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
EffRx Pharmaceuticals | Phase 2 |
Amgen | Phase 2 |
University Hospital, Ghent | Phase 2 |
US Patents and Regulatory Information for BINOSTO
BINOSTO is protected by three US patents.
Patents protecting BINOSTO
Effervescent compositions comprising bisphosphonates and methods related thereto
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Effervescent compositions comprising phosphonates and methods related thereto
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Stable effervescent bisphosphonate formulations with rapid solubilization characteristics
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ascend Theraps Us | BINOSTO | alendronate sodium | TABLET, EFFERVESCENT;ORAL | 202344-001 | Mar 12, 2012 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | Y | See Plans and Pricing | ||
Ascend Theraps Us | BINOSTO | alendronate sodium | TABLET, EFFERVESCENT;ORAL | 202344-001 | Mar 12, 2012 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
Ascend Theraps Us | BINOSTO | alendronate sodium | TABLET, EFFERVESCENT;ORAL | 202344-001 | Mar 12, 2012 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | Y | See Plans and Pricing | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for BINOSTO
See the table below for patents covering BINOSTO around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Russian Federation | 2608724 | СТАБИЛЬНЫЕ СОСТАВЫ ШИПУЧЕГО БИСФОСФОНАТА СО СВОЙСТВАМИ БЫСТРОЙ СОЛЮБИЛИЗАЦИИ (STABLE FORMULATIONS OF EFFERVESCENT BISPHOSPHONATE WITH PROPERTIES OF FAST SOLUBILIZATION) | See Plans and Pricing |
Australia | 2003284275 | EFFERVESCENT COMPOSITIONS COMPRISING BISPHOSPHONATES AND METHODS RELATED THERETO | See Plans and Pricing |
World Intellectual Property Organization (WIPO) | 03075884 | See Plans and Pricing | |
Denmark | 2648702 | See Plans and Pricing | |
Russian Federation | 2013109765 | СТАБИЛЬНЫЕ СОСТАВЫ ШИПУЧЕГО БИСФОСФОНАТА СО СВОЙСТВАМИ БЫСТРОЙ СОЛЮБИЛИЗАЦИИ | See Plans and Pricing |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for BINOSTO
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1175904 | 2007C/048 | Belgium | See Plans and Pricing | PRODUCT NAME: ALENDRONATE DE SODIUM/COLECALCIFEROL; AUTHORISATION NUMBER AND DATE: EU/1/05/310/001 20050826 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |